Yinchuan Xu

2.2k total citations · 1 hit paper
32 papers, 1.0k citations indexed

About

Yinchuan Xu is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yinchuan Xu has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Epidemiology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yinchuan Xu's work include Mesenchymal stem cell research (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Hormonal Regulation and Hypertension (3 papers). Yinchuan Xu is often cited by papers focused on Mesenchymal stem cell research (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Hormonal Regulation and Hypertension (3 papers). Yinchuan Xu collaborates with scholars based in China, United States and Germany. Yinchuan Xu's co-authors include Zhaocai Zhang, Jiabing Rong, Jianan Wang, Xinyang Hu, Hong Yu, Zhi Jiang, Rongrong Wu, Jianan Wang, Zhiwei Zhong and Hong Lü and has published in prestigious journals such as PLoS ONE, Circulation Research and Bioresource Technology.

In The Last Decade

Yinchuan Xu

29 papers receiving 1.0k citations

Hit Papers

Infla... 2025 2026 2025 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinchuan Xu China 20 477 214 197 195 188 32 1.0k
Chih‐Chao Yang Taiwan 20 436 0.9× 116 0.5× 272 1.4× 169 0.9× 139 0.7× 51 1.1k
Tiebing Zhu China 20 431 0.9× 159 0.7× 246 1.2× 104 0.5× 212 1.1× 47 1000
Shigeyoshi Oba Japan 20 422 0.9× 173 0.8× 184 0.9× 109 0.6× 147 0.8× 32 934
Gabriele Togliatto Italy 20 825 1.7× 356 1.7× 235 1.2× 160 0.8× 176 0.9× 30 1.4k
Soichiro Usui Japan 23 677 1.4× 110 0.5× 363 1.8× 146 0.7× 509 2.7× 111 1.7k
Qiujun Yu China 18 436 0.9× 124 0.6× 123 0.6× 74 0.4× 255 1.4× 28 1.1k
Ying Tong China 17 496 1.0× 131 0.6× 128 0.6× 73 0.4× 141 0.8× 34 928
Guoxian Qi China 18 373 0.8× 184 0.9× 207 1.1× 74 0.4× 259 1.4× 75 962
Bonna Ith United States 12 754 1.6× 100 0.5× 124 0.6× 168 0.9× 74 0.4× 14 1.2k
Suozhu Shi China 17 411 0.9× 187 0.9× 217 1.1× 154 0.8× 41 0.2× 39 1.1k

Countries citing papers authored by Yinchuan Xu

Since Specialization
Citations

This map shows the geographic impact of Yinchuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinchuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinchuan Xu more than expected).

Fields of papers citing papers by Yinchuan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinchuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinchuan Xu. The network helps show where Yinchuan Xu may publish in the future.

Co-authorship network of co-authors of Yinchuan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinchuan Xu. A scholar is included among the top collaborators of Yinchuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinchuan Xu. Yinchuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhaocai, et al.. (2025). Loss of Hepatic Angiotensinogen Attenuates Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction. Advanced Science. 12(43). e07554–e07554.
2.
Xu, Yinchuan, Ziyi Zhou, Kang‐Hsi Wu, et al.. (2025). Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovascular Diabetology. 24(1). 11–11. 32 indexed citations breakdown →
4.
Rong, Jiabing, et al.. (2024). The emerging role of adaptor proteins in regulating innate immunity of sepsis. Pharmacological Research. 205. 107223–107223.
5.
Zhang, Shujing, et al.. (2024). Identification of 18β-glycyrrhetinic acid as an AGT inhibitor against LPS-induced myocardial dysfunction via high throughput screening. Biochemical Pharmacology. 223. 116127–116127. 3 indexed citations
6.
7.
Hong, Min, et al.. (2022). The Emerging Role of Ferroptosis in Cardiovascular Diseases. Frontiers in Pharmacology. 13. 822083–822083. 32 indexed citations
8.
Rong, Jiabing, Yao Lin, Hong Lü, et al.. (2021). Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction. Circulation Research. 129(5). 547–564. 35 indexed citations
9.
Rong, Jiabing, et al.. (2021). Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications. Pharmacological Research. 167. 105409–105409. 24 indexed citations
10.
Xu, Yinchuan, Jiabing Rong, & Zhaocai Zhang. (2020). The emerging role of angiotensinogen in cardiovascular diseases. Journal of Cellular Physiology. 236(1). 68–78. 22 indexed citations
11.
Xu, Yinchuan, et al.. (2020). Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis. Journal of Zhejiang University SCIENCE B. 21(7). 537–548. 21 indexed citations
12.
Xu, Yinchuan, et al.. (2020). Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria. Inflammation. 43(4). 1184–1200. 86 indexed citations
13.
Rong, Jiabing, et al.. (2020). Induction of thoracic aortic dissection: a mini-review of β-aminopropionitrile-related mouse models. Journal of Zhejiang University SCIENCE B. 21(8). 603–610. 28 indexed citations
14.
Xu, Yinchuan, et al.. (2020). Intermittent ice-cooling to prevent skin heat injury caused by high-intensity focused ultrasound therapy targeting desmoid-type fibromatosis: A case report. International Journal of Nursing Sciences. 8(1). 136–140. 4 indexed citations
15.
Rong, Jiabing, Hong Lü, Alan Daugherty, et al.. (2019). Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis. Journal of Lipid Research. 60(12). 1983–1995. 21 indexed citations
16.
Rong, Jiabing, Hong Lü, Alan Daugherty, et al.. (2019). Angiotensinogen in Hepatocytes Contributes to Western Diet-Induced Liver Steatosis. SSRN Electronic Journal. 1 indexed citations
17.
Xu, Yinchuan, et al.. (2017). Attitude and Intention Regarding Pain Management among Chinese Nursing Students: A Cross-Sectional Questionnaire Survey. Pain Management Nursing. 18(4). 250–259. 10 indexed citations
18.
Wang, Chen, Han Chen, Wei Zhu, et al.. (2016). Nicotine Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice by Activating α7 Nicotinic Acetylcholine Receptor on Mast Cells. Arteriosclerosis Thrombosis and Vascular Biology. 37(1). 53–65. 52 indexed citations
19.
Xu, Yinchuan, Xinyang Hu, Lihan Wang, et al.. (2013). Preconditioning via Angiotensin Type 2 Receptor Activation Improves Therapeutic Efficacy of Bone Marrow Mononuclear Cells for Cardiac Repair. PLoS ONE. 8(12). e82997–e82997. 20 indexed citations
20.
Jiang, Zhi, Xinyang Hu, Hong Yu, et al.. (2013). Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms. Journal of Cellular and Molecular Medicine. 17(10). 1247–1260. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026